Phase IIa trial of AVN 211 in patients with schizophrenia stabilised on atypical antipsychotic therapy
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2013
At a glance
- Drugs AVN 211 (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- 15 Jul 2013 Positive top-line results published in CNS Spectrums, according to an Avineuro Pharmaceuticals media release.
- 24 Feb 2011 Top-line data reported in a Avineuro Pharmaceuticals media release.
- 10 Feb 2010 New trial record